Extendicare Class Action

The law firms of Thomson Rogers and Will Davidson LLP are working together to continue to advance a class action proceeding claiming $200 million on behalf of residents of long-term care homes owned and/or operated and/or managed by Extendicare (Canada) Inc. (“Extendicare”).

Toronto, ON, Jan. 13, 2021 (GLOBE NEWSWIRE) — The law firms of Thomson Rogers and Will Davidson LLP are working together to continue to advance a class action proceeding claiming $200 million on behalf of residents of long-term care homes owned and/or operated and/or managed by Extendicare (Canada) Inc. (“Extendicare”).

Extendicare owns and/or operates and/or manages 71 long term care facilities in Ontario, including Tendercare Living Centre in Scarborough, Ontario.

The class action includes all residents of long-term care facilities in Ontario which are owned and/or operated and/or managed by Extendicare, including Tendercare Living Centre (“Tendercare”) in Scarborough, Ontario.

As of January 11th, 2021, 73 residents have died at Tendercare as a result of COVID-19. The tragic number of deaths at Tendercare now exceeds the number of deaths at Orchard Villa in Pickering, Ontario. These are the 2 most severely impacted homes in the province by way of the number of fatalities. Both homes are managed and operated by Extendicare.

One of the victims is Ping Qiu who is survived by her 3 children, 3 grandchildren and 3 great-grandchildren. Ms. Qiu’s grandson, Reed Zhao, is seeking answers on behalf of his family to questions that were not answered by Tendercare.

“I believe my family deserves to know what happened to my grandmother. We were not provided with information regarding her condition. We have many questions as to why Tendercare was not prepared for the second wave and why Tendercare was not able to protect my grandmother.”

Tien Ngan Luu was another resident at Tendercare who tragically passed away on December 27, 2020 after contracting COVID-19. Ms. Luu leaves behind her brother, sister and 14 nieces and nephews, including Kienmy Tran. Ms. Luu’s family is haunted by the suffering and what they believe to be a lack of basic care provided to the residents at Tendercare.

“We are seeking answers to understand the events that transpired leading up to her death, accountability and justice for her and countless others who have died due to the neglect, lack of direction and preparation by management.”

A Ministry inspection was completed at Tendercare on December 16, 2020. The inspection report found that infection control practices and the availability of PPE at Tendercare were inconsistent and that as a result, COVID-19 “spread rapidly throughout the home” resulting in widespread infection and death.

On October 10, 2014, the United States Justice Department announced that Extendicare paid a $38 million dollar settlement after an investigation into some of its American facilities, which revealed substandard nursing services. When the matter settled the Associate Attorney General stated that, “it is critically important that we confront nursing home operators who put their own economic gain ahead of the needs of their residents.”

On November 7, 2014, Extendicare announced the sale of its American portfolio of senior care communities for $870,000,000.00. It is alleged that it intended to grow and expand its business in Canada.

A few months later, the owners of Orchard Villa, Southbridge Healthcare Inc., announced that they had hired Extendicare, who they described as a “recognized leader in quality clinically based services,” to work at Orchard Villa.

Extendicare continued to pay dividends to their shareholders in 2020 during the pandemic consistent with the amounts in earlier years.

NDP Federal Leader, Jagmeet Singh was quoted on June 20, 2020 commenting on Extendicare:

“This company didn’t just earn profit, but had enough profit where they gave dividends of $10 million.”

“They were able to pay back dividends to shareholders of $10 million, meaning that they’re spending that much less on their care of their residents,” Singh said.

“They’re spending that much less on staffing, and equipment, and supplies during COVID-19.”

Thomson, Rogers and Will Davidson LLP confirm,

“The tragedy at Tendercare has resulted in an unspeakable number of deaths. The Ministry of Long-Term Care findings that Extendicare still does not have consistent infection control practices and PPE are astounding. We have been in contact with dozens of families from Tendercare and other Extendicare homes and they deserve answers.”

For more information, please contact:

Will Davidson LLP

Gary Will at [email protected] (905-815-5802)
Michael Reid at [email protected] (905-337-9748)

Thomson Rogers

Stephen Birman at [email protected] (416-868 3137)
Robert Ben at [email protected] (416-868-3168)
Lucy Jackson at [email protected] (416-868-3154)



Stephen Birman
Thomson Rogers
416-868-3137
[email protected]

Ruth Fernandes
Thomson Rogers
416-868-3190
[email protected]

Aurora Strategy Group joins International Public Relations Network

One of the world’s largest and well-established independent agency networks

TORONTO, Jan. 13, 2021 (GLOBE NEWSWIRE) — Marcel Wieder, President & Chief Advocate of Aurora Strategy Group is proud to announce that the firm has joined the International Public Relations Network (IPRN). “We are excited to be a part of a dynamic and exciting group of independent international agencies that will add value to our clients and expand our reach,” said Wieder. “At the same time, we will be able to help our partners who are conducting international campaigns have boots on the ground in Canada who understand the local and nuanced considerations in dealing with the Canadian market.”

The IPRN was founded in 1995 and has 52 agency members in 41 countries in 104 cities. Luis Gonzalez, President of the IPRN welcomed Aurora saying, “We are excited to have a new Canadian partner who has a national reach and such an experienced staff. IPRN members help each other through joint projects, great connections, case studies and referrals that support their clients to meet their public relations objectives and increase business.”

IPRN is very active and brings together members annually to share best practices and strategies. As part of the meeting the IPRN Annual Awards are presented showcasing some of the best work from member agencies. “We look forward to being active members and learn from fellow agency members and PR specialists in many countries on how to help deliver our client’s message,” Wieder said. In addition, IPRN members host webinars and other activities on a variety of topics throughout the year that provides continuing knowledge to members.

“With so many Canadian firms conducting business internationally it made sense for Aurora to align itself with an international network that could provide clients with additional reach and one stop shopping,” Wieder added. “Now clients don’t need to conduct multiple searches in different markets saving them both time and money.”

About Aurora Strategy Group – An award-winning public affair, government relations and public relations firm based in Toronto with offices in Edmonton and Moncton, the multidisciplinary team is focused on ensuring Your Message. Delivered. ™

For further information:

Marcel Wieder
416-907-2126
[email protected]

 



Ed Slott, CPA, America’s IRA Expert, Named Professor of Practice at The American College of Financial Services

Slott brings his extensive IRA expertise and knowledge to The College

King of Prussia, PA, Jan. 13, 2021 (GLOBE NEWSWIRE) — George Nichols III, President and CEO at The American College of Financial Services, announced today that Ed Slott, CPA, founder of irahelp.com, has been named Professor of Practice and will be joining The College faculty. In the position, Slott, America’s IRA Expert, will contribute to the Retirement Income Certified Professional® (RICP®) program and support The College’s current faculty focused on retirement distribution planning.  

“Ed Slott has educated millions on the second half of retirement planning – how to best help clients distribute their hard-earned retirement savings and navigate potential tax pitfalls. He will bring decades of expertise to our faculty,” said Nichols. “Ed has the unique ability to communicate IRA complexities in common-sense language. His passion and wealth of knowledge will provide tremendous value to our students because he thinks with the end in mind – the application of knowledge to help financial professionals help their clients.”

As president and founder of Ed Slott and Company, LLC, a leading source of timely IRA expertise and analysis to financial advisors, institutions, and consumers, Slott brings to the RICP® program practical, easy-to-understand information on IRA and retirement distribution planning. The RICP® designation is the profession’s leading retirement income credential developed by more than 45 of the nation’s top financial retirement professionals, focusing on understanding, choosing, and executing sustainable retirement income strategies for a clients’ available resources, including best practices in Social Security claiming, evaluating and addressing risks faced in retirement, planning for long-term care needs, and more.

“I am honored to join The American College of Financial Services faculty, and I look forward to sharing my knowledge on the latest tax and retirement planning laws and strategies with even more financial professionals,” said Slott. “I have dedicated my career to educating financial professionals across the country so that they can help their clients properly and proactively prepare for the distribution phase of retirement. Through the RICP® program, I will be able to provide these highly-qualified financial professionals with the knowledge they need to confidently guide their clients through some of the most complicated retirement planning strategies.”

As a nationally recognized IRA distribution expert, professional speaker, and best-selling author, Slott has an unmatched ability to turn advanced tax strategies into understandable, actionable and entertaining advice. He was named “The Best Source for IRA Advice” by The Wall Street Journal, and USA Today wrote, “It would be tough to find anyone who knows more about IRAs than CPA Slott.”

Slott regularly presents on IRA and estate planning strategies at both consumer events and conferences for financial advisors, insurance professionals, CPAs and attorneys, including virtual events drawing thousands of attendees nationwide. He has provided topical keynote presentations for leading financial membership organizations, including the Financial Planning Association, National Association of Personal Financial Advisors, Estate Planning Councils and the American Institute of Certified Public Accountants, as well as leading corporate financial firms coast-to-coast. He is the creator of Ed Slott’s Elite IRA Advisor GroupSM, an organization of more than 450 of the nation’s top financial professionals who attend his ongoing continuing-education programs to maintain a mastery of advanced retirement account and tax planning laws.

He is an accomplished author of many financial and retirement-focused books, including most recently “Ed Slott’s Retirement Decisions Guide: 2021 Edition” (IRAHelp, 2021), “Fund Your Future: A Tax-Smart Savings Plan in Your 20s and 30s” (IRAHelp, 2021), and “The New Retirement Savings Time Bomb” (Penguin Random House, 2021), all scheduled for release in early 2021.  

As the go-to resource for media on timely insight on breaking news as it relates to retirement and tax planning laws and strategies, Slott is often quoted in The New York Times, The Wall Street Journal, Forbes, USA Today, Kiplinger, Investor’s Business Daily and numerous additional national magazines and financial publications. He provides a monthly Q&A column to AARP and is a contributing columnist and media resource to Financial Planning, Financial Advisor and InvestmentNews magazines. He has appeared on many national television and radio programs, including NBC, ABC, CBS, CNBC, CNN, FOX, FOX Business, NPR, Bloomberg and Morningstar. He is also the host of several public television specials, including his most recent, Retire Safe & Secure! with Ed Slott (2021). 

Slott is a past Chairman of the New York State Society of CPAs Estate Planning Committee and editor of the IRA planning section of the CPA Journal. He was named a 2020 InvestmentNews Innovator for his significant contribution to helping advisors improve client outcomes and tackle industry challenges as well as the 2020 Sidney Kess Award Winner for excellence in continuing education by the AICPA®. He is the recipient of the prestigious “Excellence in Estate Planning” and “Outstanding Service” awards presented by The Foundation for Accounting Education. He is a former board member of The Estate Planning Council of New York City and is Accredited Estate Planner (AEP) distinguished. 

 ### 

ABOUT THE AMERICAN COLLEGE OF FINANCIAL SERVICES

The American College of Financial Services was founded in 1927 and is the nation’s largest nonprofit educational institution devoted to financial services. Holding the highest level of academic accreditation, The College has educated one in five financial advisors across the United States and offers two master’s degrees in management and financial services, along with prestigious financial planning designations such as the Retirement Income Certified Professional® (RICP®), Chartered Life Underwriter® (CLU®), Wealth Management Certified Professional® (WMCP®), Chartered Advisor in Philanthropy® (CAP®), Chartered Special Needs Consultant® (ChSNC®), Chartered Financial Consultant® (ChFC®), and education leading to the Certified Financial Planner™ (CFP®) certification. The College’s faculty represents some of the foremost thought leaders in the financial services profession. Visit TheAmericanCollege.edu and connect with us on LinkedIn, Facebook and Twitter.

ABOUT ED SLOTT

Ed Slott, CPA, is the nationally recognized IRA and retirement planning distribution expert, best-selling author and professional speaker. His upcoming books include Ed Slott’s Retirement Decisions Guide: 2021 Edition (IRAHelp, 2021), Fund Your Future: A Tax-Smart Savings Plan in Your 20s and 30s (IRAHelp, 2021), and “The New Retirement Savings Time Bomb (Penguin Random House, 2021), all scheduled for release in early 2021. He has also hosted several public television programs, including his latest, Retire Safe & Secure! with Ed Slott (2021). As an AARP columnist, Slott also writes a monthly Q&A column where he answers consumers’ retirement planning questions. His company, Ed Slott and Company, LLC, is the nation’s leading provider of technical IRA education for financial advisors, CPAs and attorneys. Ed Slott’s Elite IRA Advisor GroupSM is comprised of nearly 450 of the nation’s top financial professionals who are dedicated to the mastery of advanced retirement account and tax planning laws and strategies. Visit irahelp.com for more information and connect with Ed Slott and Company on LinkedIn, Facebook and Twitter.

Attachment



Lindsey Allumbaugh
The American College of Financial Services
610-526-1418
[email protected]

KVH Industries’ CEO & COO/CFO to Speak at 23rd Annual Needham Growth Conference

MIDDLETOWN, R.I., Jan. 13, 2021 (GLOBE NEWSWIRE) — KVH Industries, Inc., (Nasdaq: KVHI), CEO, Martin Kits van Heyningen, and COO/CFO, Brent Bruun, will be speaking at the 23rd Annual Needham Virtual Growth Conference on Friday, January 15, 2021. The presentation, which is scheduled for 10:45 a.m. ET will be simulcast on the Internet and can be accessed via KVH Industries’ investor website, investors.kvh.com. An archive of the presentation will also be available for replay later in the day at the same website address.

About KVH Industries, Inc.

KVH Industries, Inc., is a global leader in mobile connectivity and inertial navigation systems, innovating to enable a mobile world. The market leader in maritime VSAT, KVH designs, manufactures, and provides connectivity and content services globally. KVH is also a premier manufacturer of high-performance sensors and integrated inertial systems for defense and commercial applications. Founded in 1982, the company is based in Middletown, RI, with research, development, and manufacturing operations in Middletown, RI, and Tinley Park, IL, and more than a dozen offices around the globe.

KVH is a registered trademark of KVH Industries, Inc.

For further information, please contact:

Jill Connors
Sr. Manager, Media & Industry Analyst Relations
KVH Industries, Inc.
Tel: +1 401 851 3824
[email protected]



Samsung Biologics Shares ‘Vision’ for Next Decade at the 39th Annual JP Morgan Healthcare Conference

PR Newswire

INCHEON, South Korea, Jan. 13, 2021 /PRNewswire/ — Samsung Biologics (207940.KS) set forth its dynamic growth plan for the next decade at the 2021 Annual JP Morgan Healthcare Conference. John Rim, newly appointed President and CEO, unveiled a multidimensional business plan for the company to further expand as a major player in the biopharmaceutical industry, bolstering its rapidly expanding CDMO business with a greater global footprint, continued advancements in its biosimilars subsidiary, and ultimately new drug development.

“Our next decade will be marked by increased business expansion and portfolio diversification. While continuing to achieve best-in-class CDMO services and become a champion in the biosimilars business, we will also lay the groundwork for novel drug development, to ultimately become a full-service biopharmaceutical company,” said John Rim, CEO of Samsung Biologics on Wednesday in his presentation at the Main Track of the conference, held virtually this year due to COVID-19.

To support the company’s long-term vision, Samsung Biologics announced plans to secure manufacturing facilities overseas in addition to outlining its global CDO R&D Center in multiple locations. Rim noted that product diversification from mAb/fusion protein manufacturing to encompass future modalities such as vaccines and cell-gene therapies are also being studied, and the company is further venturing into new business models for its growth roadmap.

Samsung Biologics signaled a strong year in 2020, signing over $1.7 billion in CMO contracts – a record-breaking figure – and opening the company’s first overseas CDO R&D center in San Francisco. The company also proactively developed multiple new platforms such as virtual exhibition hall and live-streaming tour technologies to enhance virtual connectivity with global clients and regulatory agencies by offering convenience and agility amid the COVID-19 pandemic.

Rim announced the company’s primary focus for the current year will be to accelerate Plant 4 construction to meet global demand, and secure early contract lock-ins for the aforementioned “Super Plant” as all other plants are expected to be near-full utilization in 2021.

“The strategic investments and portfolio diversification outlined today signify the momentum in our business, as well as lay the foundation for the long-term growth opportunity ahead of us,” Rim added. “We will look beyond the next decade and evolve as the global top-tier biopharmaceutical company by securing future growth engines with continued investment and expansion in capacity, portfolio, and global footprint.”

About Samsung Biologics Co., Ltd.

Samsung Biologics (KRX: 207940.KS) is a fully integrated CDMO offering state-of-the-art contract development, manufacturing, and laboratory testing services. With proven regulatory approvals, the largest capacity, and the fastest throughput, Samsung Biologics is an award-winning partner of choice and is uniquely able to support the development and manufacturing of biologics products at every stage of the process while meeting the evolving needs of biopharmaceutical companies worldwide. For more information, visit www.samsungbiologics.com

Media Contact

Claire Kim

[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/samsung-biologics-shares-vision-for-next-decade-at-the-39th-annual-jp-morgan-healthcare-conference-301207627.html

SOURCE Samsung Biologics

Specialized Pro-Resolving Mediators (SPMs) Shown to Resolve Inflammation and Improve Infection Clearance

These marine oil compounds show tremendous promise in context of inflammatory lung conditions

Fort Lauderdale, FL, Jan. 13, 2021 (GLOBE NEWSWIRE) — A recent review article describes how compounds called specialized pro-resolving mediators (SPMs) may be a viable treatment for inflammatory lung conditions, acute respiratory distress syndrome and chronic obstructive pulmonary disease, as shown in preclinical settings.  

The article, Specialized Proresolving Mediators in Infection and Lung Injury, by Dr. Shayna Sandhaus and Dr. Andrew G. Swick, was published in November in Biofactors, a journal of the International Union of Biochemistry and Molecular Biology. It looked at SPM’s effectiveness across a wide range of animal models.

“Specialized pro-resolving mediators, or SPMs, control the inflammation resolution process,” explained study co-author Dr. Andrew G. Swick, Chief Scientific Officer at Life Extension®. “Basically, these compounds help tissue return to a healthy state. This is important because chronic inflammation is best managed by both limiting inflammation in the first place and promoting the resolution of that inflammation after it occurs.”

Your body makes SPMs out of long-chain polyunsaturated fatty acids, like you’d find in fish oil. But SPMs work differently than traditional omega-3s in that they help to resolve inflammation (instead of preventing it, the way anti-inflammatory drugs do, or, to a lesser extent, EPA and DHA fatty acids from fish oil).  Inflammation is an issue with all diseases, including lung disease and respiratory infections, so learning how to resolve inflammation is a discovery that could not have come at a more opportune moment.

“SPMs have shown tremendous potential for treating infectious diseases and lung conditions,” Dr. Shayna Sandhaus, co-author of the article, explained. “Administering SPMs in preclinical studies has led to infection clearance, resolution of lung inflammation, and improved survival rates.”

SPMs have additional benefits as well; these specialized pro-resolving mediators can be used to treat a wide variety of ailments associated with chronic inflammation, the study confirmed, such as periodontitis (gum disease), sepsis, tuberculosis and even bacterial pneumonia. “We believe SPMs could prove to be a useful tool for managing many inflammatory conditions,” Dr. Sandhaus said.

For more information on SPMs, please read our recent Life Extension Magazine® article.

About Life Extension®

 

For 40 years, Life Extension has pursued innovative advances in health, conducting rigorous clinical trials and setting some of the most demanding standards in the industry to offer a full range of wellness information and services. Life Extension’s Wellness Specialists provide personalized counsel to help customers choose the right products for optimal health, nutrition and personal care. To learn more, visit LifeExtension.com.



Rey Searles
Life Extension
954-766-8433
[email protected]

Konica Minolta Wins 12 BLI Awards from Keypoint Intelligence for its bizhub i-Series, Including ‘A3 Line of the Year’

Devices Particularly Stand Out with Regard to Reliability, Quality and Usability

Ramsey, NJ, Jan. 13, 2021 (GLOBE NEWSWIRE) — Konica Minolta is proud to announce it has received 12 Buyers Lab (BLI) Awards from Keypoint Intelligence, the world’s leading and independent evaluator of document imaging hardware, software and services. This is an acknowledgment of the capabilities of Konica Minolta’s multi-functional peripheral devices (MFPs) with the leading industry awards. All devices are from Konica Minolta’s new bizhub i-Series, underlining the successful relaunch of the company’s MFP range. In addition to 10 BLI 2021 Pick Awards for its bizhub A3 MFPs, Konica Minolta secured the BLI 2021 A3 Line of The Year Award. Based on long-term comprehensive testing, Konica Minolta was further acknowledged with the BLI 2021-2023 Most Color Consistent A3 Brand Award.

Companies demand consistent quality, reliability and the highest levels of usability from their office printers – and it is in exactly these areas that Konica Minolta’s A3 bizhub i-Series range impressed the testers from Keypoint Intelligence. Twelve Konica Minolta bizhub A3 MPFs received the Highly Recommended overall rating for outstanding performance in Keypoint Intelligence lab testing. Ten of those models earned Pick Awards in their respective segments: bizhub C250i, C300i, C450i, C550i, C650i, 300i, 360i, 450i, 550i and 750i. This earned Konica Minolta additionally the ‘BLI 2021 A3 Line of the Year’ award.

“Thank you to Keypoint Intelligence for this honor. We are tremendously proud to be recognized for the best A3 product line in the market,” said Dino Pagliarello, Senior Vice President, Product Management and Planning, Konica Minolta Business Solutions, U.S.A., Inc. “As an organization that has expanded into many different areas, we have remained true to this industry and driving our core business by continuing to incorporate advanced technology and functionality to improve customer experience. Winning BLI’s 2021 A3 Line of the Year Award is a testament to our unwavering dedication.”

This underlying philosophy in product design is the basis for the high usability of the devices and offers a high degree of end-to-end ease of use. For example: The large control panels provide easy access to all basic settings and touch navigation for a pleasant and effective user experience. The panel can be fully customized with all tools and apps a specific user most frequently needs. Further, the preinstalled MarketPlace on all devices gives access to a wide range of cloud offerings.

The BLI 2021-2023 Most Color Consistent A3 Brand further shows that Konica Minolta’s MFPs are able to deliver repeatable high-quality printing results: For this award, BLI analyzed color consistency for well over 20 years and the last five years of results have been included in this evaluation. Technicians print IT8 color charts at specific test points throughout a device’s reliability test, which are then measured using Xrite i1Profiler software together with the i1Pro2 spectrophotometer/iO table combination.

About Konica Minolta

Konica Minolta Business Solutions U.S.A., Inc. is reshaping and revolutionizing the Workplace of the Future™ with its expansive smart office product portfolio, from IT Services (All Covered), ECM, Managed Print Services and industrial and commercial print solutions. Konica Minolta has been recognized as the #1 Brand for Customer Loyalty in the MFP Office Copier Market by Brand Keys for thirteen consecutive years, and the World Technology Awards recently named the company a finalist in the IT Software category. Konica Minolta, Inc. has been named to the Dow Jones Sustainability World Index for nine consecutive years and has spent three years on the Global 100 Most Sustainable Corporations in the World list. Konica Minolta partners with its clients to give shape to ideas and work to bring value to our society. For more information, please visit us online and follow Konica Minolta on FacebookYouTubeLinkedIn and Twitter.

About Konica Minolta Business Solutions (Canada) Ltd.

Konica Minolta Business Solutions (Canada) Ltd. is reshaping and revolutionizing the Workplace of the Future™. With our comprehensive portfolio, we deliver solutions to leverage mobility and cloud services and optimize business processes with workflow automation. Konica Minolta’s IT Services Division offers a range of IT strategy, support and network security solutions across all verticals. Konica Minolta has been recognized by Brand Keys as the #1 Brand for Customer Loyalty in the MFP Office Copier market for 13 consecutive years. Konica Minolta, Inc. has been named to the Dow Jones Sustainability World Index for eight years in a row. We partner with our customers to give shape to ideas and work to bring value to our society. For more information, please visit www.konicaminolta.ca and follow Konica Minolta on LinkedInYouTubeFacebook and Twitter (@KonicaMinoltaCA).

# # # # #

Konica Minolta Business Solutions (Canada) Ltd. Press Contact
Konica Minolta Media Relations – Canada
[email protected]

Attachment



Maggie Grande
Konica Minolta Business Solutions U.S.A., Inc.
551-500-2659
[email protected]

Cascade Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing January 15, 2021

NEW YORK, NY, Jan. 13, 2021 (GLOBE NEWSWIRE) — Cascade Acquisition Corp. (the “Company” or “CAS”) announced that, commencing January 15, 2021, holders of the units sold in the Company’s initial public offering may elect to separately trade shares of the Company’s Class A common stock (“Class A Common Stock”) and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Class A Common Stock and warrants that are separated will trade on The New York Stock Exchange under the symbols “CAS” and “CAS.WS,” respectively. Those units not separated will continue to trade on The New York Stock Exchange under the symbol “CAS.U.”

The units were initially offered by the Company in an underwritten offering. Credit Suisse Securities (USA) LLC and Morgan Stanley & Co. LLC acted as joint book-running managers for the offering. Keefe, Bruyette & Woods, Inc. acted as lead manager for the offering.

The public offering was made only by means of a prospectus, copies of which may be obtained from Credit Suisse Securities (USA) LLC by mail: Attention: Prospectus Department, 6933 Louis Stephens Drive, Morrisville, North Carolina 27560, by phone: 1-800-221-1037, by e-mail: [email protected] or Morgan Stanley & Co. LLC by mail: Attention: Prospectus Department, 180 Varick Street, Second Floor, New York, NY 10014.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Cascade Acquisition Corp.

Cascade Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue targets in any industry, it intends to focus its search in the financial services industry.

Forward-Looking Statements

This press release may include, and oral statements made from time to time by representatives of CAS may include, “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions, as they relate to the Company or its management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company’s filings with the Securities and Exchange Commission (“SEC”). All subsequent written or oral forward-looking statements attributable to the Company or persons acting on its behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Company Contact: 

Jay Levine, Chief Executive Officer
Cascade Acquisition Corp.
1900 Sunset Harbour Dr.
Suite 2102
Miami Beach, Florida 33139



Enabling Technologies from HEIDENHAIN to Showcase at SLAS2021

-For medical and lab automation-

San Jose, CA, Jan. 13, 2021 (GLOBE NEWSWIRE) — HEIDENHAIN is proud to showcase motion control enabling technologies at the upcoming SLAS2021 digital exposition on January 25-27.  This annual global conference and expo by SLAS (Society of Lab Automation and Screening) welcomes scientists, engineers and business leaders from academia, government and industry to immerse themselves in the latest life sciences discovery and technology research and new products that can change the world. 

As a long-time world leader and provider of precision measurement and motion control components and systems, HEIDENHAIN is committed to supporting the medical technology and laboratory automation fields with state-of-the-art equipment as they continually must meet increasing demands for accuracy, precision, speed, and cost savings. HEIDENHAIN brands IMT, ETEL, RENCO and AMO will be represented at SLAS2021.

For those at SLAS looking for lab automation solutions for high throughput in sample analysis, HEIDENHAIN will showcase linear encoders, linear motors, motion control systems and read-out systems. 

And for those with a specific microfluidic challenge, HEIDENHAIN Life Sciences will highlight offers of NGS, organ-on-a-chip, single-cell analysis, cell enrichment, sample preparation and many more.

 Information and the opportunity to connect with HEIDENHAIN experts will be available during the SLAS expo.

 Click here to register for SLAS2021https://www.slas.org/events-calendar/slas2021/

#

About HEIDENHAIN

DR. JOHANNES HEIDENHAIN GmbH, headquartered in Traunreut, Germany, develops and supports motion control feedback solutions for the machine tool, semiconductor, electronics assembly and test, metrology, automation, medical, energy, biotechnology and other global markets. HEIDENHAIN employs approximately 6,000 people worldwide in its core business activities. The North American subsidiary is HEIDENHAIN CORPORATION, headquartered in Schaumburg, IL, and San Jose, CA, and has been serving the U.S. industry for over 50 years. Here nine company brands are represented. More information at: www.heidenhain.us/about-us

 

Downloadable digital image at:   https://www.heidenhain.us/addl-materials/pr/2021/NGS-flow-cell.jpg

 

Attachment



Kathleen Herrmann
K-Pro PR Inc
224-520-0665
[email protected]

Medigus Closes $8.4 Million Underwritten Public Offering of American Depositary Shares

OMER, Israel, Jan. 13, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq, TASE: MDGS) (“Medigus” or “the Company”), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced the closing of an underwritten public offering of 3,659,735 American Depositary Shares (the “ADSs”). Each ADS was sold to the public at a price per ADS of $2.30. The gross proceeds to the Company from this offering are expected to be approximately $8.4 million before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.

The Company intends to use the net proceeds from this offering for working capital and general corporate purposes.

The Company has also granted the underwriter an option to purchase an additional 15 percent of the ADSs offered in the public offering solely to cover over-allotments, if any, exercisable until the earlier of 30-days or the last day of trading of the Company’s ordinary shares on the Tel-Aviv Stock Exchange prior to their delisting which would increase the total gross proceeds of the offering to approximately $9.6 million, if exercised in full.

Aegis Capital Corp. acted as sole bookrunner for the offering.

This offering was made pursuant to an effective registration statement on Form F-3 (No 333-238162) previously filed with the U.S. Securities and Exchange Commission (the “SEC”) and declared effective by the SEC on May 15, 2020. A final prospectus describing the terms of the proposed offering has been filed with the SEC and is available on the SEC’s website located at http://www.sec.gov.

Electronic copies of the final prospectus may be obtained by contacting Aegis Capital Corp., Attention: Syndicate Department, 810 7th Avenue, 18th floor, New York, NY 10019, by email at [email protected], or by telephone at (212) 813-1010.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Medigus

Medigus is traded on the Nasdaq Capital Market and the TASE (Tel Aviv Stock Exchange). To learn more about the Company’s advanced technology, please visit www.medigus.com.

Cautionary Note Regarding Forward Looking Statements

This press release may contain statements that are “Forward-Looking Statements,” which are based upon the current estimates, assumptions and expectations of the Medigus’ management and its knowledge of the relevant market. Medigus has tried, where possible, to identify such information and statements by using words such as “anticipate,” “believe,” “envision,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “target,” “potential,” “will,” “would,” “could,” “should,” “continue,” “contemplate” and other similar expressions and derivations thereof in connection with any discussion of future events, trends or prospects or future operating or financial performance, although not all forward-looking statements contain these identifying words. For example, Medigus uses forward looking statements when describing the proposed use of proceeds.  These forward-looking statements represent Medigus’ expectations or beliefs concerning future events, and it is possible that the results described in this press release will not be achieved, due to inter alia the spread of COVID-19 as well as the restriction deriving therefrom. By their nature, Forward-Looking Statements involve known and unknown risks, uncertainties and other factors which may cause future results of Medigus activity to differ significantly from the content and implications of such statements. Other risk factors affecting Medigus are discussed in detail in Medigus’ filings with the Securities and Exchange Commission. Forward-Looking Statements are pertinent only as of the date on which they are made, and Medigus undertakes no obligation to update or revise any Forward-Looking Statements, whether as a result of new information, future developments or otherwise. Neither Medigus nor its shareholders, officers and employees, shall be liable for any action and the results of any action taken by any person based on the information contained herein, including without limitation the purchase or sale of Medigus’ securities. Nothing in this press release should be deemed to be medical or other advice of any kind.

Investor Contact

Tatiana Yosef
Chief Financial Officer
+972-8-6466-880
[email protected]